PNF Contract-Relax-Agonist-Contract (CRAC)

Classification

Element	Detail
Category	PNF Stretching
Subcategory	Contract-relax-agonist-contract (CRAC)
FOMTRAC	Supports PCs 3.3a (ROM exercises), 3.3d (stretching)
Fritz Method	Joint movement (active contraction of target + active contraction of antagonist + passive stretch)

Purpose

Achieve maximum ROM gains by activating both autogenic inhibition and reciprocal inhibition simultaneously
Overcome significant muscle tightness or adaptive shortening that does not respond adequately to contract-relax or hold-relax alone
Restore functional ROM in rehabilitation settings where the greatest possible ROM gain per session is needed

Mechanism

CRAC works in three phases that layer two distinct inhibitory mechanisms: Phase 1 — Target muscle contraction (autogenic inhibition): The client contracts the target muscle isometrically at 50-75% MVC for 5-10 seconds at the movement barrier. This strong contraction maximally loads the Golgi tendon organs at the musculotendinous junction, producing robust Ib afferent signaling. When the contraction ceases, GTO-mediated autogenic inhibition suppresses alpha motor neuron output to the target muscle for approximately 10-15 seconds. Phase 2 — Relaxation: The client relaxes completely for 2-3 seconds. Phase 3 — Antagonist contraction + stretch (reciprocal inhibition added): The client actively contracts the antagonist muscle (the muscle opposite the target) while the therapist simultaneously stretches the target into new range. The antagonist contraction activates Ia inhibitory interneurons via Sherrington's law of reciprocal innervation, producing additional inhibition of the target muscle. This reciprocal inhibition stacks on top of the still-active autogenic inhibition from Phase 1. The result: the target muscle is being inhibited by two independent neurological pathways simultaneously — GTO-mediated autogenic inhibition (from the preceding contraction of the target) plus Ia interneuron-mediated reciprocal inhibition (from the concurrent contraction of the antagonist). This dual inhibition produces greater muscle relaxation and larger ROM gains than either mechanism alone.

Indications

Significant ROM limitation that does not respond adequately to contract-relax or hold-relax alone
Athletic rehabilitation requiring maximum ROM restoration per session
Chronic muscle shortening with strong resting tone in clients who tolerate strong contraction forces
Post-immobilization stiffness (cast removal, prolonged bed rest) where rapid ROM recovery is needed
Hypertonic muscles resistant to single-mechanism stretching approaches
Muscle imbalance presentations where the target is overactive and the antagonist is underactive (CRAC simultaneously inhibits the target and activates the antagonist)

Contraindications

Acute muscle tear or strain in either the target or antagonist muscle
Acute inflammation in the target muscle, antagonist, or joint
Osteoporosis — the strong isometric contraction and stretch force may risk fracture
Acute fracture at or near the joint
Hypermobility of the associated joint
Uncontrolled hypertension — isometric contraction transiently elevates blood pressure
Client unable to understand or follow the two-contraction sequence (cognitive impairment, language barrier without interpreter)
Recent corticosteroid injection to the target area (48-72 hours)
Weak or painful antagonist muscle (if the client cannot actively contract the antagonist, use contract-relax instead)

Effects

Immediate:

Dual-pathway inhibition: GTO autogenic inhibition + Ia reciprocal inhibition acting simultaneously on the target muscle
ROM gains of 8-25 degrees per cycle (greater than contract-relax alone)
Temporary reduction in muscle tone and resting resistance to stretch
Simultaneous facilitation/activation of the antagonist muscle

Cumulative (repeated application over sessions):

Progressive and sustained increases in muscle extensibility
Reduced neural drive to chronically hypertonic muscles
Improved agonist-antagonist coordination and muscle balance
Strengthened antagonist muscle (dual benefit similar to reciprocal inhibition MET)
Functional restoration of movement patterns limited by tightness

Risks and Side Effects

Post-stretch soreness (more pronounced than hold-relax or contract-relax due to the combined forces involved)
Muscle strain if contraction force exceeds tissue tolerance (in either the target or antagonist)
Transient blood pressure elevation during the isometric contraction phase
Overstretching if the therapist is too aggressive during the dual-inhibition window
Client confusion with the two-contraction sequence (requires clear instruction and sometimes a practice round)
Delayed onset muscle soreness (24-48 hours)
Cramping in the antagonist muscle during its contraction phase

Expected Outcomes

Short-term (same session): ROM increases of 8-25 degrees per treatment cycle — the largest gains of any single PNF stretching technique. Client reports significantly reduced tightness. Palpable decrease in resting muscle tone. Medium-term (over 4-6 sessions): Sustained and progressive ROM gains that exceed those achieved with contract-relax alone. Improved agonist-antagonist muscle balance. Functional improvements in activities limited by the restriction.

Execution

1. Position the client so the target muscle can be stretched through its full available range. Stabilize the proximal segment. 2. Move the limb passively to the first barrier — the point of firm tissue resistance. 3. Instruct the target muscle contraction: "Push against my hand at about 50-75% of your maximum effort." Hold the isometric contraction for 5-10 seconds. Match their force — the joint should not move. 4. Instruct the client to relax completely. Allow 2-3 seconds for full relaxation. 5. Instruct the antagonist contraction + stretch: "Now actively push your [limb] in this direction [toward the stretch] while I help you stretch further." The client contracts the antagonist while the therapist simultaneously moves the limb past the previous barrier into new range. Hold for 10-15 seconds. 6. Return to neutral slowly. 7. Repeat 3-5 times. Each cycle should achieve progressively more range. Key principles:

Phase 1 (target contraction) is ISOMETRIC — no joint movement
Phase 3 (antagonist contraction) involves MOVEMENT — the client actively pushes while the therapist assists the stretch
The antagonist contraction must begin immediately after the relaxation pause to capitalize on the still-active autogenic inhibition from Phase 1
Each cycle starts from the new barrier, not the original position

Lubricant: Not required. Breathing coordination: Client inhales during the target muscle contraction (Phase 1), exhales during relaxation and the antagonist contraction/stretch phase (Phases 2-3).

Parameters

Parameter	Range	Clinical Reasoning
Target contraction intensity	50-75% MVC	Strong enough for robust GTO activation
Target contraction duration	5-10 sec	Sufficient to load GTOs and produce post-isometric inhibition
Relaxation pause	2-3 sec	Allows cessation of voluntary motor activity; do not wait too long or the inhibition window begins to close
Antagonist contraction intensity	20-50% MVC	Sufficient to activate reciprocal inhibition pathway; does not need to be maximal
Stretch + antagonist hold	10-15 sec	Takes up the new range during the dual-inhibition window
Repetitions	3-5 per muscle	Progressive ROM gain with each cycle; diminishing returns beyond 5
Stretch intensity	Firm but tolerable (4-6/10)	Stronger stretch is possible because the muscle is doubly inhibited

Clinical Notes

Common error: Allowing too much time between the target contraction (Phase 1) and the antagonist contraction (Phase 3). The autogenic inhibition window from the target contraction is time-limited (10-15 seconds). If the therapist delays, the GTO inhibition fades and only the reciprocal inhibition remains — effectively reducing CRAC to a simple reciprocal inhibition technique.
Common error: Having the client contract the antagonist before relaxing the target. The target must relax FIRST. Co-contraction (both muscles contracting simultaneously) is stabilization, not stretching.
What to feel for: A distinctly greater "give" during the stretch phase compared to contract-relax alone. If the ROM gain per cycle is not noticeably larger than with contract-relax, verify that the client is actually contracting the antagonist.
When to stop: If ROM does not increase after 2-3 cycles (the restriction may be capsular). If the client reports sharp pain during any phase. If the client cannot coordinate the two-contraction sequence after instruction.
Clinical pearl: CRAC is most valuable for clients with strong muscles and significant restrictions — the dual mechanism justifies the added complexity. For mildly tight muscles or pain-sensitive clients, hold-relax or contract-relax is usually sufficient. Reserve CRAC for the cases where you need maximum ROM gains and the client can handle the instruction complexity.
The dual benefit: Like reciprocal inhibition MET, the antagonist contraction in CRAC simultaneously inhibits the overactive target and facilitates the underactive antagonist. This makes CRAC particularly useful for muscle imbalance presentations.

Verbal Script

> "We're going to use a technique that combines two steps to get the maximum stretch. First, I'll bring your [limb] to the end of its range. Then I'll ask you to push against my hand at about half to three-quarters of your strength for 5 seconds — that's the [target muscle] contracting. After that, relax completely. Then I'll ask you to actively push your [limb] in the opposite direction while I help stretch you further. Ready? Push against me... hold... and relax. Good — now push toward [stretch direction] while I stretch... hold... and ease off. Let's do that again."

Distinguishing Features

Feature	CRAC	Contract-Relax (CR)
Inhibitory mechanisms	BOTH autogenic inhibition + reciprocal inhibition	Autogenic inhibition only
Number of client contractions	Two (target then antagonist)	One (target only)
Typical ROM gain per cycle	8-25 degrees	5-20 degrees
Instruction complexity	Higher (two contractions, two directions)	Moderate (one contraction)
Client coordination required	More demanding	Less demanding
Antagonist activation	Yes — simultaneously facilitates the antagonist	No
Best for	Maximum ROM gain needed; muscle imbalance presentations	Significant restriction; clients who struggle with two-contraction instructions

The key distinction: CRAC adds a reciprocal inhibition component on top of the autogenic inhibition already produced by the target contraction. This dual mechanism produces the largest ROM gains of any single PNF stretching technique but requires more client coordination and instruction time. Contract-relax is simpler and nearly as effective for most clinical presentations.

Key Takeaways

CRAC is the most neurologically complete PNF stretching technique — it activates both autogenic inhibition (GTO reflex from target contraction) and reciprocal inhibition (Ia pathway from antagonist contraction) simultaneously
Produces larger ROM gains per cycle (8-25 degrees) than contract-relax or hold-relax alone because both inhibitory mechanisms are active during the stretch
Requires more client coordination than other PNF techniques — the client must perform two contractions in sequence (target at 50-75% MVC, then antagonist at 20-50% MVC)
The antagonist contraction must begin promptly after the target relaxes to capitalize on the still-active autogenic inhibition window
Reserve for cases requiring maximum ROM gains — for most clinical presentations, contract-relax or hold-relax provides sufficient gains with less instruction complexity